Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01335789 · ClinicalTrials.gov registry record · NA
Effect of Oxytocin on Stress in Marijuana Users
A NA study of Marijuana Dependence, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
- 1
- Study location
NCT01335789 is a NA study of Marijuana Dependence that has completed, run by Medical University of South Carolina. The registered enrollment target is 16 participants, below the 90-participant average among 6 other Marijuana Dependence trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01335789, a NA study of Marijuana Dependence, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate how people who frequently use marijuana respond to a stressful task, and if a medication (oxytocin) affects this response.
Conditions Studied
Interventions
- DRUG Saline
- DRUG Oxytocin
Study Locations (1)
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2011-03 |
| Est. Completion | 2012-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01335789
The ClinicalTrials.gov registry entry for NCT01335789 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 90-participant average among 6 other Marijuana Dependence trials with a reported enrollment target (82% lower). The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Marijuana Dependence appearing as the primary indexed condition, and to 2 interventions - of which Saline is the first listed.
NCT01335789 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.
Frequently Asked Questions
What is clinical trial NCT01335789 about?
NCT01335789 is a clinical study titled "Effect of Oxytocin on Stress in Marijuana Users". The purpose of this study is to evaluate how people who frequently use marijuana respond to a stressful task, and if a medication (oxytocin) affects this response.
What is the current status of trial NCT01335789?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2011-03. Estimated completion is 2012-07.
What conditions does trial NCT01335789 study?
This clinical trial studies the following conditions: Marijuana Dependence.
What interventions are being tested in trial NCT01335789?
The interventions under investigation include: Saline (DRUG), Oxytocin (DRUG).
Who is sponsoring clinical trial NCT01335789?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01335789 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Marijuana Dependence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of Oxytocin on Craving and Therapy Response
COMPLETED · NA
-
Marijuana Treatment Project 4
COMPLETED · NA
-
Vilazodone Treatment for Marijuana Dependence
COMPLETED · Phase 2
-
Effect of Baclofen on Marijuana Withdrawal and Relapse
COMPLETED · Phase 2
-
Buspirone Treatment for Marijuana Dependence
COMPLETED · Phase 4
-
Effectiveness Study of Dronabinol and BRENDA for the Treatment of Cannabis Withdrawal
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.